PharmaVOICE - 
January 2018
Purchase Issue

In Every Issue
Letter from the Editor
Tired of “innovation“ yet? No doubt that innovation is one [...]
By

Taren Grom, Editor

Upfront
Merck Expands Donation Program Merck has expanded the Mectizan Donation [...]
By

PharmaVOICE Staff

Innovator’s Corner
Next-Generation Immuno-Oncology Stephen Isaacs, President and CEO of Aduro Biotech, [...]
By

Stephen Isaacs, President and CEO of Aduro Biotech

HealthTech
Apple Watch Expands Capabilities to improve health outcomes in cardiac, [...]
By

PharmaVOICE Staff

Last Word
Supporting Caregivers Scott Williams, VP, Head of Global Patient Advocacy [...]
By

Scott Williams, VP, Head of Global Patient Advocacy and Strategic Partnerships, EMD Serono

On The Cover

Pharma Innovation Labs
Innovative or collaborative partnerships in pharma are being touted by some as the “new normal.” Certainly, this is true of several pioneering pharmaceutical companies in the space, but authentic, independent or open-source collaborations are still a minority in the life-sciences ecosystem. The bright spot is that there are several companies that have created in-house innovation [...]
By

Robin Robinson

Features

Disruptive Advertising
Technology disruptions in our world are becoming routine, and consumers are becoming impervious to the daily assault on their attention. In order to be effective, brand marketers need to rise above and beyond an ever-rising bar of campaign creativity, as well as use technology to break through all the noise that distracts their audiences. This [...]
By

Robin Robinson

Next-Generation Nanomedicines
The first generation of nanotechnology-based medicines, including nano-based drug delivery systems and nanovectors, improved the safe delivery of therapies that were once toxic. Nanoparticles have also proven to be especially good vehicles to effectively deliver cancer drugs, where many therapies are toxic in high doses, because they can minimize or negate potential off-target effects. Nano-delivery [...]
By

Denise Myshko

Pricing Front and Center
Pharmaceutical pricing is a complex — and often controversial — issue impacting all stakeholders in healthcare. Discussions around value, fair pricing, transparency, outcomes, and patient affordability are front and center as companies try to provide some insight, but each stakeholder in this group of cohorts has very different needs. There is no easy way to [...]
By

Denise Myshko

SHOWCASE FEATURE: Social Media: Taking the Plunge: Pharma and Social Media
Pharmaceutical companies are increasingly embracing social media as a forum for reaching patients. For example, 40% of adults use social media for health-related issues, such as connecting with patients with similar issues. Social forums allow pharmaceutical companies to not only engage with consumers or patients, but also hear what they have to say directly, rather [...]
By

PharmaVOICE Staff

“I Want My Brand on Social!”
Social media is ubiquitous. Everyone is on it in some capacity. We are all hands-on experts; but social is very nuanced. How do I leverage creative, messaging, audience, device, time of day, etc., to connect with my customers? A successful start requires focus on a strategy—one that is as individual as the person you are [...]
By

Joe Youssef, Engagement Strategist, and Dara Ligouri, Engagement Strategist, Ogilvy CommonHealth Worldwide

Transcending Traditional Social Media: From Awareness to Uncovering Actionable Insights
It goes without saying that social media is one of the most widely used forms of communication today. Pharmaceutical companies are trying to “crack the code” and understand how to effectively use this channel to achieve organizational initiatives while complying with rigorous industry regulations. Progressive companies have navigated this challenging environment, breaking new ground and [...]
By

Dr. Theodore Search, Pharm.D., CEO and Founder, Skipta

Industry Gears Up For Track and Trace
Counterfeit medicines have taken a huge toll, both in terms of human costs as well as financially. Interpol estimates that 1 million deaths each year can be linked to counterfeits. According to PwC, counterfeit pharmaceuticals are a 0 billion-plus annual business. The problem is most severe in lower income countries with between 10% and 30% [...]
By

Kim Ribbink

Women’s Healthcare: Drug Development
With a U.S. healthcare market estimated at .8 trillion and purchasing either made or largely influenced by women, the “power of the purse” has never been stronger. According to Carolyn Buck Luce, executive-in-residence at the Center for Talent Innovation and an adjunct professor at Columbia University who teaches Women and Power, and co-founder of Imaginal [...]
By

Taren Grom, Editor

Red Zone: Applying User Experience Design to Develop Effective Patient Suport
Treatment nonadherence is a complex behavior that requires much more than a simple one-size-fits-all approach to address the challenge. What can pharma learn from the behavioral sciences to deliver patient support that is effective in improving tx adherence? Health psychology and behavioral economics provide us with theories and insights to develop effective patient support programs [...]
By

Kate Perry, MSc, PsychD, Director, Behavioral Science, Atlantis Healthcare

FEEDBACK